Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Sep;41(9):1871–1875. doi: 10.1128/aac.41.9.1871

Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma.

K M Wasan 1, M Ramaswamy 1, S M Cassidy 1, M Kazemi 1, F W Strobel 1, R L Thies 1
PMCID: PMC164027  PMID: 9303376

Abstract

The physical characteristics and lipoprotein distribution of free nystatin (NYS) and liposomal NYS (L-NYS) in human plasma were investigated. To determine the percentage of NYS that was lipid associated following incubation in human plasma, C18 reverse-phase extraction columns were used. To assess plasma drug distribution, NYS and L-NYS (20 microg/ml) were incubated in human plasma for 5, 60, and 120 min at 37 degrees C. After each interval, plasma was removed and separated into its lipoprotein and lipoprotein-deficient plasma (LPDP) fractions by ultracentrifugation and assayed for NYS by high-pressure liquid chromatography. Further studies evaluated the liposome structure of L-NYS by filtering through a 0.14-microm-pore-size microfilter before and after the addition of human plasma. When reconstituted L-NYS (mean particle diameter +/- standard deviation, 321 +/- 192 nm) was applied to a C18 column, 67% +/- 4% of the initial NYS concentration was associated with the lipid. When plasma samples containing L-NYS that had been incubated for 5 to 120 min at 37 degrees C were applied to C18 columns, 66 to 76% of the NYS was lipid associated. Incubation of NYS in human plasma for 5 min at 37 degrees C resulted in 3% +/- 1% of the initial NYS concentration incubated in the low-density lipoprotein (LDL) fraction, 23% +/- 4% of that in the high-density lipoprotein (HDL) fraction, and 66% +/- 10% of that in the LPDP fraction. In contrast, the distribution of NYS following incubation of L-NYS in human plasma for 5 min was 13% +/- 2% in the LDL fraction, 44% +/- 5% in the HDL fraction, and 42% +/- 5% in the LPDP fraction. Similar results were observed following 60 and 120 min of incubation. In addition, the liposome structure of L-NYS was quickly lost when mixed with plasma. These findings suggest that rapid disruption of the L-NYS structure upon incubation in human plasma is consistent with its rapid distribution in plasma. The preferential distribution of NYS into the HDL fraction upon incubation of L-NYS may be a function of its phospholipid composition.

Full Text

The Full Text of this article is available as a PDF (187.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dhondt F., Ninane J., De Beule K., Dhondt A., Cauwenbergh G. Oral candidosis: treatment with absorbable and non-absorbable antifungal agents in children. Mycoses. 1992 Jan-Feb;35(1-2):1–8. doi: 10.1111/j.1439-0507.1992.tb00812.x. [DOI] [PubMed] [Google Scholar]
  2. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Koldin M. H., Kobayashi G. S., Brajtburg J., Medoff G. Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits. Antimicrob Agents Chemother. 1985 Jul;28(1):144–145. doi: 10.1128/aac.28.1.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Krieger M. The use of amphotericin B to detect inhibitors of cellular cholesterol biosynthesis. Anal Biochem. 1983 Dec;135(2):383–391. doi: 10.1016/0003-2697(83)90700-5. [DOI] [PubMed] [Google Scholar]
  5. Lopez-Berestein G., Rosenblum M. G., Mehta R. Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans. Cancer Drug Deliv. 1984 Summer;1(3):199–205. doi: 10.1089/cdd.1984.1.199. [DOI] [PubMed] [Google Scholar]
  6. Medoff G., Brajtburg J., Kobayashi G. S., Bolard J. Antifungal agents useful in therapy of systemic fungal infections. Annu Rev Pharmacol Toxicol. 1983;23:303–330. doi: 10.1146/annurev.pa.23.040183.001511. [DOI] [PubMed] [Google Scholar]
  7. Mehta R. T., Hopfer R. L., Gunner L. A., Juliano R. L., Lopez-Berestein G. Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis. Antimicrob Agents Chemother. 1987 Dec;31(12):1897–1900. doi: 10.1128/aac.31.12.1897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Schaffner C. P., Mechlinski W. Polyene macrolide derivatives. II. Physical-chemical properties of polyene macrolide esters and their water soluble salts. J Antibiot (Tokyo) 1972 Apr;25(4):259–260. [PubMed] [Google Scholar]
  9. Selvam M. P., Blay R. A., Geyer S., Buck S. M., Pollock L., Mayner R. E., Epstein J. S. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents. AIDS Res Hum Retroviruses. 1993 May;9(5):475–481. doi: 10.1089/aid.1993.9.475. [DOI] [PubMed] [Google Scholar]
  10. Stevens N. M., Engle C. G., Fisher P. B., Mechlinski W., Schaffner C. P. In vitro antiherpetic activity of water-soluble amphotericin B methyl ester. Arch Virol. 1975;48(4):391–394. doi: 10.1007/BF01317438. [DOI] [PubMed] [Google Scholar]
  11. Thies R. L., Cowens D. W., Cullis P. R., Bally M. B., Mayer L. D. Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma. Anal Biochem. 1990 Jul;188(1):65–71. doi: 10.1016/0003-2697(90)90528-h. [DOI] [PubMed] [Google Scholar]
  12. Wasan E. K., Reimer D. L., Bally M. B. Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. J Pharm Sci. 1996 Apr;85(4):427–433. doi: 10.1021/js9504752. [DOI] [PubMed] [Google Scholar]
  13. Wasan K. M., Brazeau G. A., Keyhani A., Hayman A. C., Lopez-Berestein G. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins. Antimicrob Agents Chemother. 1993 Feb;37(2):246–250. doi: 10.1128/aac.37.2.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wasan K. M., Conklin J. S. Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated levels of low-density lipoprotein cholesterol. Clin Infect Dis. 1997 Jan;24(1):78–80. doi: 10.1093/clinids/24.1.78. [DOI] [PubMed] [Google Scholar]
  15. Wasan K. M., Lopez-Berestein G. Characteristics of lipid-based formulations that influence their biological behavior in the plasma of patients. Clin Infect Dis. 1996 Nov;23(5):1126–1138. doi: 10.1093/clinids/23.5.1126. [DOI] [PubMed] [Google Scholar]
  16. Wasan K. M., Lopez-Berestein G. The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers. Arch Med Res. 1993 Winter;24(4):395–401. [PubMed] [Google Scholar]
  17. Wasan K. M., Morton R. E. Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin. Pharm Res. 1996 Mar;13(3):462–468. doi: 10.1023/a:1016065114515. [DOI] [PubMed] [Google Scholar]
  18. Wasan K. M., Morton R. E., Rosenblum M. G., Lopez-Berestein G. Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein. J Pharm Sci. 1994 Jul;83(7):1006–1010. doi: 10.1002/jps.2600830716. [DOI] [PubMed] [Google Scholar]
  19. Wasan K. M., Perez-Soler R. Distribution of free and liposomal annamycin within human plasma is regulated by plasma triglyceride concentrations but not by lipid transfer protein. J Pharm Sci. 1995 Sep;84(9):1094–1100. doi: 10.1002/jps.2600840912. [DOI] [PubMed] [Google Scholar]
  20. Wasan K. M., Rosenblum M. G., Cheung L., Lopez-Berestein G. Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B. Antimicrob Agents Chemother. 1994 Feb;38(2):223–227. doi: 10.1128/aac.38.2.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wasan K. M., Vadiei K., Lopez-Berestein G., Luke D. R. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. J Infect Dis. 1990 Mar;161(3):562–566. doi: 10.1093/infdis/161.3.562. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES